CN Stock MarketDetailed Quotes
688298 Zhejiang Orient Gene Biotech
Watchlist
39.50
+0.33+0.84%
Market Closed 12/01 15:00 CST
39.93High38.79Low20.83KlotVolume
39.22Open39.17Pre Close81.91MTurnover1.03%Turnover RatioLossP/E (TTM)7.96BMarket Cap97.4852wk High3.85P/E (Static)201.60MShares34.5252wk Low1.02P/B7.96BFloat Cap239.66Historical High47.00Limit Up201.60MShs Float27.74Historical Low31.34Limit Down2.91%Amplitude10.75KlotAsk1.67Dividend TTM39.32Avg Price9.50KlotBid4.22%Div YieldTTM100Lot Size
Zhejiang Orient Gene Biotech Key Stats
EPS
According to the latest financial report of Zhejiang Orient Gene Biotech, the latest earnings per share (TTM) for the company is -0.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Zhejiang Orient Gene Biotech's latest financial report to see how much their book value per share (BVPS) is currently at 38.59.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zhejiang Orient Gene Biotech shows that the company's current ratio is 7.90, indicating healthy liquidity.
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zhejiang Orient Gene Biotech, the quick ratio is 7.40, indicating that the company can meet its short-term debt obligations.
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Zhejiang Orient Gene Biotech? The latest ROE figure is -0.91%, indicating that the company has stable profitability.
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zhejiang Orient Gene Biotech, the total asset return on investment (ROA) is -0.68%.
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zhejiang Orient Gene Biotech's latest financial report to see how their gross margin is doing - currently at 37.14%.
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zhejiang Orient Gene Biotech, the net profit margin is -10.31%, which is a good sign for its profitability.
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.